Johnson & Johnson [JNJ] stock is trading at $186.05, up 0.34%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The JNJ shares have gain 5.30% over the last week, with a monthly amount glided 4.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on September 23, 2025, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $206 for it. Previously, Erste Group upgraded its rating to Buy on July 23, 2025. On May 13, 2025, downgrade downgraded it’s rating to Market Perform but maintained its price target of $153 on the stock. Wolfe Research initiated its recommendation with an Outperform and recommended $190 as its price target on November 15, 2024. Daiwa Securities downgraded its rating to Neutral for this stock on July 23, 2024, and downed its price target to $150.
Johnson & Johnson [JNJ] stock has fluctuated between $140.68 and $185.99 over the past year. Currently, Wall Street analysts expect the stock to reach $162 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $186.05 at the most recent close of the market. An investor can expect a potential drop of -12.93% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
Johnson & Johnson [NYSE:JNJ] reported sales of 90.62B for the trailing twelve months, which represents a growth of 5.76%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.3%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.3 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 184.45 points at the first support level, and at 182.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 187.10, and for the 2nd resistance point, it is at 188.16.
Ratios To Look Out For
For context, Johnson & Johnson’s Current Ratio is 1.01. Also, the Quick Ratio is 0.76, while the Cash Ratio stands at 0.34. Considering the valuation of this stock, the price to sales ratio is 4.94, the price to book ratio is 5.71 and price to earnings (TTM) ratio is 19.90.
Transactions by insiders
Recent insider trading involved Taubert Jennifer L, EVP, WWC. Innovative Medicine, that happened on Sep 04 ’25 when 56471.0 shares were sold. Officer, Taubert Jennifer L completed a deal on Sep 04 ’25 to buy 56471.0 shares. Meanwhile, Officer Forminard Elizabeth bought 9570.0 shares on Aug 29 ’25.
